Repetitive/temporal hypoxia increased P-glycoprotein expression in cultured rat brain microvascular endothelial cells

Liu Xiao-Dong1, Yang Zhi-Hong, Yang Hui-Wen

  • 1Key Lab of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing 210009, China. xdliu@cpu.edu.cn

Neuroscience Letters
|February 5, 2008
PubMed

Insights

Repetitive temporal hypoxia increases P-glycoprotein (P-gp) levels in rat brain endothelial cells. This suggests hypoxia may cause P-gp overexpression, potentially contributing to drug resistance in epilepsy.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pharmacology

Background:

  • The blood-brain barrier (BBB) regulates substance entry into the brain.
  • P-glycoprotein (P-gp) is a key efflux transporter at the BBB.
  • Understanding factors affecting P-gp is crucial for treating brain disorders.

Purpose of the Study:

  • To investigate the effect of repetitive/temporal hypoxia on P-glycoprotein (P-gp) expression and function in cultured rat brain microvascular endothelial cells (rBMECs).
  • To explore the potential role of hypoxia-induced P-gp changes in conditions like refractory epilepsy.

Main Methods:

  • Primary rat brain microvascular endothelial cells (rBMECs) were cultured to form an in vitro BBB model.
  • Cells were subjected to daily repetitive/temporal hypoxic exposure for up to 8 days.
  • P-gp levels were assessed using Western blot, and P-gp function was evaluated by measuring rhodamine 123 and phenobarbital uptake.

Main Results:

  • Eight days of repetitive/temporal hypoxia significantly increased P-gp levels by 1.6-fold in rBMECs.
  • Hypoxia led to decreased cellular accumulation of rhodamine 123, indicating reduced P-gp function.
  • The uptake of phenobarbital, another substrate of P-gp, was also decreased.

Conclusions:

  • Repetitive/temporal hypoxia up-regulates P-glycoprotein expression and function in brain microvascular endothelial cells.
  • Hypoxia-induced P-gp overexpression may be a contributing factor to the development of P-gp-mediated drug resistance in refractory epilepsy.
  • This study highlights hypoxia as a potential therapeutic target for improving drug delivery across the BBB in neurological disorders.

Related Concept Videos